Public Spending in Russia for Health Care : Issues and Options
This report examines three critically important areas to inform discussions on the appropriate level of health care spending in the Russian Federation: (i) the efficiency of spending on health care services; (ii) distributional impacts of spending on health care services; and (iii) the key factors that will influence the growth in health care spending over the next 20 years. There are few data showing how spending in health care in the Russian Federation translates into better health outcomes such as improved mortality, improved morbidity, increased economic output and productivity, improvements in the number of life years gained, or more sophisticated composite measures such as Quality Adjusted Life Years (QALYs). There is also limited data on outputs of hospitals and other healthcare providers which allow controlling for case mix, socioeconomic status, supply-side variables, and quality of care. Therefore, it is difficult to assess the efficiency or distributional impacts of health interventions. While the analysis draws on primary data specifically collected for the study, the absence of detailed output and outcome data necessarily limits the scope of the study and its findings.
Summary: | This report examines three critically
important areas to inform discussions on the appropriate
level of health care spending in the Russian Federation: (i)
the efficiency of spending on health care services; (ii)
distributional impacts of spending on health care services;
and (iii) the key factors that will influence the growth in
health care spending over the next 20 years. There are few
data showing how spending in health care in the Russian
Federation translates into better health outcomes such as
improved mortality, improved morbidity, increased economic
output and productivity, improvements in the number of life
years gained, or more sophisticated composite measures such
as Quality Adjusted Life Years (QALYs). There is also
limited data on outputs of hospitals and other healthcare
providers which allow controlling for case mix,
socioeconomic status, supply-side variables, and quality of
care. Therefore, it is difficult to assess the efficiency or
distributional impacts of health interventions. While the
analysis draws on primary data specifically collected for
the study, the absence of detailed output and outcome data
necessarily limits the scope of the study and its findings. |
---|